Cogent Biosciences, Inc. Other Non-Current Liabilities
Cogent Biosciences, Inc. (COGT) had Other Non-Current Liabilities of $90.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Liabilities, Noncurrent $90.00K.
- 2026-03-31: Other Liabilities, Noncurrent $62.00K.
- 2025-12-31: Other Liabilities, Noncurrent $33.00K.
- 2025-09-30: Other Liabilities, Noncurrent $2.37M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $90.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $62.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $33.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $2.37M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.36M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $5.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |